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ABSTRAK
Tujuan: menganalisis hubungan komposisi mikrobiota terhadap ekspresi HSP70 dan Caspase-3 pada 
jaringan kolon pasien yang menjalani kolonoskopi dalam upaya pengembangan kandidat deteksi dini untuk 
pasien kanker kolorektal di Indonesia. Metode: penelitian potong lintang dilakukan pada 32 responden yang 
menjalani pemeriksaan kolonoskopi. Selanjutnya diketahui bahwa 16 orang adalah penderita kanker kolorektal, 
sementara 16 lainnya bukan kanker kolorektal (yaitu kolitis dan hemorrhoid interna). Komposisi mikrobiota 
pada sampel feses diperiksa dengan menggunakan 16S rRNA Denaturing Gradient Gel Electrophoresis 
(DDGE) sedangkan pemeriksaan immunohistokimia untuk menilai ekspresi HSP70 dan Caspase-3 diperiksa 
dengan pewarnaan Haematoxylin-Eosin(HE) untuk mengetahui perubahan morfologis pada jaringan kolon. 
Hasil: analisis dengan PCR-DGGE menunjukkan perbedaan komposisi mikrobiota yang terdapat pada pasien 
kanker kolorektal dan bukan penderita kanker kolorektal. Semua pasien dengan kanker kolorektal menunjukkan 
hilangnya pita dominan pada kelompok Bifidobacterium. Pengamatan histologi yang dihitung berdasarkan 
uji Inter Class Corelation (ICC) didapati skor yang cukup tinggi (5,2-9,2) pada pasien kanker dan skor yang 
lebih rendah (1,7-2,4) pada pasien bukan kanker kolorektal. Ekspresi HSP70 mengalami peningkatan secara 
signifikan pada pasien kanker kolorektal dengan persentase tertinggi yaitu 84%, sebaliknya, ekspresi Caspase-3 
mengalami penurunan dengan persentase tertinggi hanya 21%. Hasil analisis statistik menunjukkan bahwa 
kejadian kanker kolorektal berhubungan dengan ekspresi HSP70 (p<0,001) dan berhubungan dengan ekspresi 
Caspase-3 (p<0,001). Kesimpulan: penelitian ini mengindikasikan bahwa Bifidobacterium menjadi indikator 
penting terhadap pasien kanker kolorektal yang ditunjukkan pada gambaran pita yang menghilang, sedangkan 
ekspresi HSP 70 mengalami peningkatan dan ekspresi Caspase 3 terjadi penurunan yang signifikan.
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ABSTRACT
Aim: to investigate the relationship between microbiota composition with HSP70 and Caspase-3 expressions 
in colon tissue as an initial study to develop the candidate for early detection of colorectal cancer for Indonesian 
patients. Methods: this is a cross-sectional study on 32 patients undergoing colonoscopy; 16 patients of colorectal 
cancer (CRC) while the other 16 patients are not (colitis and internal hemorrhoid). The composition of microbiota 
in stool samples was examined using 16S rRNA Denaturing Gradient Gel Electrophoresis (DDGE) while expression 
of HSP70 was examined by immunohistochemistry and Caspase-3 by using Haematoxylin-Eosin(HE) staining to 
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determine the morphological changes in colon tissue. Results: analysis of PCR-DDGE shows a different composition 
of microbiota between patients with CRC and non-CRC. All CRC patients showed disappearance of dominant band 
from Bifidobacterium groups. Histological observation based on Inter Class Correlation (ICC) test from all slide 
showed a high scores (5.2-9.2) in CRC patients and low scores (1.7-2.4) in non-CRC patients. HSP70 expression 
was increased significantly in CRC patients with the highest percentage of 84%, while expression of caspase-3 
decreased with the highest percentage of 21%. Statistical analysis showed that the incidence of colorectal cancer 
was associated with the expression of HSP 70 (p<0.001), and Caspase 3 (p<0.001). Conclusion: bifidobacterium is 
an important indicator for colorectal cancer patients that show disappearance of dominant band, while expression 
of HSP70 increased and the Caspase-3 expression decreased significantly.
Keywords: bifidobacterium, Caspase-3, colorectal cancer, HSP70, microbiota.
INTRODUCTION
Colorectal cancer is the fourth most prevalent 
cancer worldwide.1 Colorectal cancer incidence 
in 2000 accounted for around 579,000 deaths. 
It is equivalent to 1% of total deaths and 
around 8% of total death related to malignant 
neoplasms. The rate of colorectal cancer is 
5-10 times higher in the developed countries.2 
In Indonesia, colorectal cancer is associated 
with the increasing evidences of cancer-related 
mortality in recent years. Medical Service 
Directorate, Department of Health Collaboration 
and Indonesian Pathology Anatomy Association 
in Jakarta reported that colorectal cancer 
patients aged under 45 years old are around 
47.85%. Whereas in an epidemiological report 
between 1996-1999 from Pathology Anatomy 
Department of Medical Faculty, Universitas 
Indonesia, colorectal cancer in patients under 
40 years are around 36.75%.3
Colorectal cancer is a disease from an 
accumulation of genetic mutation, epigenetic, 
disregulation in signaling communications 
pathways, and gut microbial contribution. 
Over the last few decades, many studies have 
explored a disease related to gastrointestinal 
tracks. Between 1990-2009 periods, there 
is an increasing number of researches about 
microbiota, almost five times in every year.4 The 
complex gut microbiota community may play an 
important role in the development of colorectal 
cancer. One of the interesting discussions 
related to this research is the important role of 
microbiota in gastrointestinal tracts that have 
pathogenic character and the pathomechanism 
of those bacteria. Colorectal cancer is a disease 
that has closely related with fiber consumption 
and microbiota in gastrointestinal tracts. The 
composition of microbiota on the colon are 
already reported as a marker in colorectal 
cancer patients. The microbiota imbalance 
is reported in several studies related to this 
disease, such as the increase of Clostridium spp., 
Bacteroides and Bifidobacterium spp.5 Other 
report is about the population of Fusobacterium 
which was increased, but Bacteroidetes and 
Firmicuteswere decreased.6 Those discoveries 
were also supported by the Pyro-sequencing 
assay at region V3 from 16S ribosomal RNA 
gene and it was found that there are close 
relationship between colorectal cancers with 
the imbalance of microbiota compared to the 
healthy individual.7
The imbalance of microbiota composition 
can be caused by significant decrease of 
butyrate-producing microbes in gastrointestinal 
t racts  such as  Firmicutes  (especial ly 
Roseburia spp. and Eubacteriumrectale) and 
Actinobacteria (such as Bifobacterium spp. and 
Collinselaaerofaciens).8-10 Butyrate production 
protects the bowel from colitis and colorectal 
cancer through lowering of oxidative damage 
of DNA, triggering the occurrence of apoptosis 
of DNA cells on the cells that already damage, 
suppressing the growth of tumor cells, and 
decreasing the activity of co-carcinogenic 
enzyme.8
Several in vitro studies showed that butyrate 
induce expression of heat shock protein (HSP) 70 
that has function in the beginning of apoptosis.11 
Caspase, which is an aspartate-specific cysteine 
proteases, has an important function on apoptosis 
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and inflammation and contribute mainly to the 
balancing of the gastrointestinal tract. In the rat 
model with colorectal cancer, it was reported 
that there is a relation between caspase 3 and 
the microbiota structure.12
In this study, we reported the relationship 
between the gut microbiota community structures 
and severity colorectal cancer compared to non-
colorectal cancer patients that have several 
characteristics related to colorectal cancer in 
Aceh Province, as initial candidate to develop 
the novel early detection for Indonesian specific 
patients. Besides that, we also measured the 
expression of HSP70 and Caspase-3 as a protein 
marker in correlation with colorectal cancer 
condition.
METHODS
This is a cross-sectional study on 32 patients 
undergoing colonoscopy. There were 16 patients 
of colorectal cancer (CRC) while the other 16 
patients are not (colitis and hemmorhoid interna). 
The biopsy was done on all patients subject to 
indication with several criteria. Inclusion criteria 
of colorectal cancer patients were proven to 
have colorectal cancer by colonoscopy and 
histopathology; did not get any antibiotics; not in 
youghurt consumption; or laxative medicine for 
the last five weeks, and Indonesian citizen that 
proved by identity cards. Informed consent was 
obtained from all subjects before participation. 
One fecal sample was collected from each control, 
and from each patient before colonoscopy. The 
study was approved by the Ethical Review 
Committee of Medical Faculty, Syiah Kuala 
University, Banda Aceh, Indonesia, registration 
number: 333/KE/FK/2015.
DNA Chromosome Isolation
Patients were prepared for feces examination 
with diet limitation. Feces specimens were 
carefully taken and grown in MRS agar for 
48-72 hours. Growth bacteria colonies were 
taken for DNA isolation. DNA isolation was 
conducted based on previous method13 with 
some modification. DNA was diluted using TE 
buffer at pH 7.6.
The primer was designed to amplify 
several bacterial groups that usually found 
in human gastrointestinal tracts. There were 
primer sets to amplify universal bacteria, 
Bacteroides, Bifidobacterium, Enterobacterium, 
Lachnospiraceae, and Erec groups. Preliminary 
study was done to test all primer. Results 
of preliminary study (data not shown) 
showed a difference between sample only 
appears on four sets of primer: Universal 
bacteria, Bifidobacterium, Enterobacterium, 
Lactobacillus. Therefore, the study was focused 
on four sets of primer without using primer that 
amplifying Lachnospiraceae or Bacteroides.
Denatured Gradient Gel Electrophoresis 
(DGGE) Analysis of Bacterial 16S rRNA in 
Stool Samples
In this study, primers were used to amplifying 
region of 16S rRNA based on previous studies 
by Vanhoutte et al.14 and Maukonen et al.15 
Every primer that used in this study was listed 
in Table 1. Forward or reverse primer from 
every primer sets was added with GC-clamp on 
5’ side to increase detection from PCR products 
with DGGE. Polymerase chain reaction (PCR) 
was conducted using GoTaq green master mix 
(Promega). Program PCR was done as follow: 
940C for 3 minutes; 30 cycles of 940C for 30 
second, 550C for 30 second and 720C for 1 
minute; and final extension of 720C for 5 minutes. 
Product of PCR was analyzed using DGGE 
(Biorad). The number of DGGE bands was used 
as an indicator of fecal bacterial diversity for each 
participant. Similarities between banding patterns 
in the DGGE profile were calculated based on 
the presence and absence of bands and expressed 
as a similarity coefficient. DGGE analysis was 
conducted based on manufacturer’s protocols in 
combination with several previous study with 
some modification.16-18
Histopathological Analysis and Immunohisto-
chemistry
Observations for colorectal  cancer 
were conducted by making the histology 
slide. To ensure the representativeness of 
each area selected in the paraffin blocks for 
immunohistochemical analysis, two samples 
were collected from different sections of the same 
block.A biopsy from patients was fixated on 10% 
formalin solution, followed by organ cutting and 
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dehydration using serial alcohol (70%, 90%, 
Absolute), each for 60 minutes. The sample 
was cleared with xylol for 30 minutes. Then it 
was continued with impregnation, embedding 
and sectioning of paraffin blocks. The slide was 
stained using Haematoxylin-Eosin. Observation 
was conducted using electronic microscope 
BX-53 (Olympus). Histology classification 
was determined based on Lanza et al.19, which 
classified the appearance as follow:
• Category 1: Negative for neoplasia (+)
• Category 2: Indefinite for neoplasia (++)
• Category 3: Mucosal low grade neoplasia, 
low grade adenoma, low grade dysplasia 
(+++)
• Category 4: Mucosal high grade neoplasia, 
high grade adenoma/dysplasia, non-
invasive carcinoma, suspicious for invasive 
carcinoma, intramucosal carcinoma, 
intramucosal carcinoma (++++)
• Category 5: sub mucosal invasion by 
carcinoma (+++++)
The expression of HSP70 and caspase-3 on 
the slides were examined and scored with colour 
proportion by Leake Scoring20, that direct count 
of the proportion of stain, stain intensity plus a 
measure of intensity of stain with two different 
pathologists
Statistical Analysis
Statistical analysis was conducted using 
SPSS 16.0 for windows. Data was analyzed using 
Chi square for the relationship of composition 
gut microbiota between CRC and non-CRC 
patients and T test to determine the expression 
of HSP70 and caspase-3 in relation to different 
clinicopathological characteristics patients. Tests 
were considered significant when P-value were 
less than 0.05.
RESULTS
A total of 16 patients with positive colorectal 
cancer and 16 non-colorectal cancer were 
included in this study. Patients demography 
and clinical features were shown in Table 2. All 
patients from two groups had similar average 
age. Almost all variable on general clinical 
observation from two groups were comparable, 
except for LED in which colorectal cancer group 
showed almost twice average value than control 
group. The clinicopathological characteristics 
of the 32 patients are shown in Table 3. The 
most common chief complain were diarrhea and 
hematochezia with most result of colonoscopy 
is carcinoma of rectum. The most frequent 
histopathogical and CT scan of patients were 
stage IV.
Analysis of PCR-DGGE from patients and 
control subject showed a different appearance 
(Figure 1). The result of DGGE from PCR 
product using primer for universal bacteria (line 
1), Enterobacterium (line 3) and Lachnospiraceae 
(line 4) groups resulted in similar band between 
colorectal cancer patient and healthy patient.  The 
different appearance was found in PCR products 
using primer for Bifidobacterium groups (line 
2). Patients with colorectal cancer did not show 
any band appearance. In contrast, control subject 
showed one clear band of + 500bp.
Results of PCR-DGGE did not show any 
dominant band from Bifidobacterium groups in 
all patients with colorectal cancer. In contrast, all 
Table 1. Primer for amplification of 16S rRNA region from bacterial colony
Primer Primer sequence (5’-3’) Target group References
V6-V8: U968-GC GC clamp-TACGGGAGGCAGCAG Universal groups 14,15
V6-V8: L1401 ATTAACCGCGGCTGCTGG
g-Bifid F CTCCTGGAAACGGGTGG Bifidobacterium 14
g-Bifid R-GC GC-clamp-GGTGTTCTTCCCGATATCTACA
Ent. 1017F CCTTTGACCACTCTAGAG Enterobacterium 14
Ent. 1263R-GC GC-clamp-CTTAGCCTCGCGACT
Lac1 AGCAGTAGGGAATCTTCCA Lactobacillus 14
Lac2-GC GC-clamp-ATTYCACCGCTACACATG
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Table 2. Demography and clinical features from each patients
Variables Colorectal cancer patients  mean (SD)
Non-colorectal cancer patients 
mean (SD)
Age (years) 50.06 (13.37) 53.06 (21.93)
BMI (kg/m2) 21.06 (4.51) 24.16 (2.70)
Hb (g/dL) 9.39 (2.27) 12.00 (1.44)
Erythrocytes (106sel/mm3) 4.21 (0.70) 5.14 (1.25)
Leukocytes (103/mm3) 8.20 (2.11) 8.14 (2.75)
Platelet (103/mm3) 318.69 (101.40) 255.83 (107.47)
Hematocrite (%) 34.47 (5.32) 36.19 (3.82)
LED (mm/1jam) 64.81 (27.47) 33.06 (13.22)
Blood sugar (mg/dL) 107.87 (17.12) 96.00 (36.84)
SGOT (U/L) 31.33 (7.69) 30.44 (5.74)
SGPT (U/L) 31.80 (8.55) 27.00 (7.48)
Albumin (g/dL) 2.77 (0.31) 3.56 (0.38)









Sex 9 (56.00) 11 (69.00)
Male 7 (44.00) 5 (31.00)
Female
Complaint
Chronic Diarrhea 8 (50.00) 5 (31.00)
Hematochezia 8 (50.00) 11 (69.00)
Colonoscopy
 - Ca Rectum 11 (68.75) 0 (0.00)
 - Ca Colon 
Descending
5 (31.25) 0 (0.00)
Colitis Infection 0 (0.00) 14 (87.50)
 - Colitis Infection 
+ Hemorrhoid 
Interna
0 (0.00) 2 (12.50)
Stadium
 - I 0 (0.00)
 - II 1 (6.25)
 - III 6 (37.50)
 - IV 9 (56.25)
patients that only have several symptoms related 
to colorectal cancer showed one dominant band 
of Bifidobacterium groups. The summaries of 
dominant band appearance from all samples 
were shown in Table 4.
Histological observation of all samples 
resulted in various appearances (Figure 2). 
Results from IHC staining were shown between 
the expression of Caspase-3 and HSP-70. In 
patients with colorectal cancer, there was a 
relatively increasing of HSP-70 and decreasing 
of Caspase-3 expression. In contrast, control 
subjects that only showed several similar 
symptoms with colorectal cancer showed a lower 
expression of HSP-70 compared to Caspase-3.
Quantitative measurement of Caspase-3 and 
HSP-70 supported the results of IHC observation 
and correlated with the severity of colorectal 
cancer (Figure 3). Among samples of patients 
with colorectal cancer, sample P4 showed the 
highest expression of HSP-70 (84%). Besides 
that, the lowest expression of caspase-3 was 
also obtained from sample P4 (21%). Sample 
P8 and P3 showed significantly lower HSP-70 
expression among these groups. Both, P8 and 
P3 sample showed no significant differences 
in percentage (53% and 49%, respectively). 
With a different group of patients that have 
colorectal cancer, among a group of control 
patients almost a similar expression of HSP-70 
and Caspase-3 were resulted. The expression of 
Caspase-3 in this group was higher compared to 
the expression of HSP-70. Opposite expression 
of Caspase-3 and HSP-70 were showed in 
comparison between those two groups.
Statistical analysis from three variables 
(bacterial composition, caspase-3, and HSP-70) 
showed a corelation between analysis results 
and disease appearance in Table 5. Analysis 
Fauzi Yusuf                                                                                                                 Acta Med Indones-Indones J Intern Med
294
Figure 1. The 16S-RNA profile identified by PCR-DGGE analysis. Different band appearance was obtained from the sample, 
especially from the PCR product that using primers to amplify bacteroides groups. M=marker; P=patient with positive colorectal 
cancer; C=control subject with characteristics of colorectal cancer; Line 1=universal bacteria; Line 2=bacteroides; Line 
3=bifidobacterium; line 4=lachnospiraceae.
Table 4. Interpretation of 16S-RNAs bands from PCR-DGGE analyses of all samples
Sample
Universal Bacteria Bifidobacterium Enterobacterium
Lachnospiraceae Grade
+ 190 bp + 200 bp + 500 bp + 370 bp
P1 to 16 + + - + - 3
C1 to C16 + + + + - 4
+ = appear (1); - = not appear (0) , P=patient, C=control
showed that colorectal cancer condition affected 
the HSP-70 and caspase-3 expression (Table 6).
DISCUSSION
Bacterial content and number that formed the 
gut microbiota has been recognized to be able to 
cause gastrointestinal diseases and disorders such 
as colorectal cancer.21,22 Imbalance composition 
of bacteria can increase the proliferation of 
carcinogenic bacteria that affect the production 
of carcinogenic compounds, secondary bile acids 
and cholesterol metabolites, finally trigger the 
ephitelium change and pathogenesis of cancer 
colorectal.23,24 Analysis of PCR-DGGE showed 
a significant difference in term of dominant band 
appearance correlated with Bifidobacterium 
groups. Patients with colorectal cancer did not 
show any appearance of the dominant band from 
Bifidobacterium groups. Bifidobacterium is the 
normal habitat in healthy human gut beside other 
species such as Faecalibacterium prausnitzii, 
Roseburia intestinalis, Bacteroides uniformis, 
and lactobacilli groups.24 The alteration of this 
bacteria becomes one of the most common 
feature related with the disease appearance.26-29 
Dysbiosis condition which cause the change 
of bacteria complexity and instability such as 
increasing in Bacteroides and Clostridia and 
a reduction in Bifidobacterium are present in 
various gastrointestinal related diseases.30 Our 
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Figure 2. Comparison of histopatological observed between patient with colorectal cancer and non-colorectal cancer with 
similar symptoms using immunohistochemistry and HE staining. Inflammation area was shown on slides that stained with 
hematoxylin-eosin from patients. The appearance of inflammation area was observed from HE staining. Result of IHC was 
showed opposite expression between HSP-70 and Caspase-3on two groups of samples. (Scale: 400x)
Figure 3. Intensity of HSP-70 and Caspase-3 expression of colorectal cancer were valued from Immunohistochemistry analysis. 
In patients with colorectal cancer, the expression of HSP-70 was higher compared to caspase-3 expression. On the contrary 
with control subject patients, the expression of HSP-70 was lower comparing to caspase-3 expression. 
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result related with the loss of Bifidobacterium 
was almost similar with previous results by 
Gueimonde et al.31 They reported a decrease 
number, or change in species composition 
of genus Bifidobacterium in patients with 
colorectal cancer. Other study by Sobhani et 
al.32 showed that several species of bacteria were 
decreased in patient with cancer compared to 
normal person such as Bifidobacterium longum, 
Clostridium clostridioforme, Ruminococcus sp., 
Ruminococcus bromii.
Bifidobacterium are bacterial groups that 
have several characteristics such as non-
motile, non-spore-forming, non-gas producing, 
gram-positive, anaerobic, catalase-negative 
bacteria with high GC content.33,34 Generally, 
morphology of this bacteria is bifid or irregular 
V-or Y-shaped rods resembling branches. 
Previous study in infants showed that large 
number of bifidobacterium was found in breast-
fed infants and lower in infantile diarrhea. 
Bifidobacterium was used for therapy in infants 
with intestinal diarrhea. Mix between freeze-
dried of Bifidobacterium and Lactobacillus are 
usually used as a treatment for person having 
Table 5. Bivariate analysis of the relationship composition gut microbiota between CRC and non-CRC patients
Group
Bacterial Composition
Total, n (%) pEnterobacterium
(+/- 370 bp), n (%)
Bifidobacterium  
(+/- 500 bp), n (%)
CRC patient 16 (100.00) 0 (0.00) 16 (100.00) <0.001
Non-CRC patient 0 (0.00) 16 (100.00) 16 (100.00)
Total 16 (50.00) 16 (50.00) 32 (100.00)
* Chi-square test
Table 6. Distinctive profile of caspase-3 and HSP-70 
between CRC and non-CRC patients (N=32)
Group mean (SD) p*
Caspase-3
 - CRC patient 80.43 (7.85) <0.001
 - Non-CRC patient 91.37 (5.70)
HSP-70
 - CRC patient 89.73 (5.55) <0.001
 - Non-CRC patient 79.51 (4.90)
*T test independent
gastrointestinal disorders.35
Although the specific function of this bacteria 
is still unclear, but based on its high colonization 
in infant gut than adult, it is possible that the 
main function of this bacteria is related with 
gut microbiota development. This suggestion 
is supported by several studies which showed 
the interaction with other microbes in gut, 
essspecially related with the digestion process 
of polysaccharides.36 Other possible functions 
of this bacteria are production of water-soluble 
vitamins; controlling certain bacteria that can 
be harmfull to the host37; producing several 
antimicrobial compounds such as organic acids, 
iron-scavenging38 and bacteriocins39,40; and also 
affecting the host innate immune response.41,42 In 
term of its function for controlling other bacteria 
growth, it is related with several clinical studies 
that showed opposite total number between this 
bacteria and other bacteria with possiblity to 
become harmfull in host gut. Besides that, the 
total number of Bifidobacterium is inversely 
correlated with the concentration of compounds 
and its related enzyme that can caused intestinal 
decay.35 Therefore, it could be understood that 
the decreasing number of Bifidobacterium 
will increase the appearance of other pathogen 
bacteria and finally affecting the occurrence of 
colorectal cancer. Our study has also proved that 
suggestion.
In recent years, several studies have been 
conducted to identify the potential usage of 
food with probiotic (such as lactobacilli or 
bifidobacteria) and/or prebiotic content in 
affecting the selectively growth of bacteria and 
in turn change the bacteria composition that 
could prevent gastrointestinal diseases including 
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cancer colorectal.21 Several studies showed the 
usage of Bifidobacterium either alone or in 
combination with other bacteria or substrates 
for cancer treatment and prevention using mouse 
model21 and human.43 Possible mechanisms 
of probiotic affecting the gut microbiota are 
through modifying the pH44 and increasing 
the short-chain fatty acid (SCFA) (especially 
acetate, propionate and butyrate); suppress 
the pathogen bacteria through production of 
antimicrobial and antibacterial; stimulating 
the immunomodulatory cells; competing with 
pathogens for nutrients, receptors and growth 
factors.21
Measurements of HSP-70 expression 
showed a significantly higher concentration 
in cancer pantients compare to non-colorectal 
cancer patients. This protein is a member of heat 
shock protein family and known as molecular 
chaperones. Several important role of this protein 
family are transferring protein into correct 
subcellular compartments; folding and protein 
forming; avoid the protein degradation; cell 
growth, development, differentiation and gene 
transcription. It is also related to the development 
and severity of cancer. Overexpression of this 
protein was observed in tumor tissues and cancer 
cell lines in which it will affect the protection 
of tumor cell and suppresing the apoptosis 
mechanism. It could be considered that the HSPs 
family is related with the cancer incidents.45 
Zhang et al.45 reported that transcription factor of 
HSPs family such as HSP-60, HSP-70 and HSP-
90α were elevated significantly on colorectal 
cancer patient compare to para-cancerous tissue. 
Other previous study also showed increasing of 
HSP-70 on esophageal carcinoma and colorectal 
cancer. In normal cells, HSPs are involved in cell 
growth and metabolism and strictly regulated 
by cell cycle. The increasing expression of 
HSPs is related with the stress condition in cells 
and affecting several process such as mediate 
proper holding and transmembrane transport 
of the oncogen and anti-oncogenes products; 
regulate the degradation of mismatching protein 
and harmonize quick metabolism balance of 
the protein in tumor cells to support the cells 
growth; and increase the tumor cells résistance 
to apoptosis.45
In our study, the measurement of caspase-3 
was inversely related with HSP70. Patients 
with colorectal cancer showed a significant 
decrease in expression of caspase-3 compared 
to non-colorectal cancer patients. Previous study 
related with caspase-3 measurement also showed 
in decrease concentration on colorectal cancer 
patients and affecting the cancer prognosis.47 
The caspase-3 and HSP-70 expression is 
correlated each other. Several studies show 
that increasing of HSP-70 could suppress the 
caspase-3 expression.48,49 A study of colorectal 
cancer treated with a cancer related drug, EGCG, 
has shown the ability of this compound to bind 
to the HSP-70 and suppress its expression. The 
decrease in HSP-70 affect the increase in caspase 
3 and activation of the apoptosis mechanisms. 
Caspase-3 is cytokine that related to apoptosis 
mechanism. This cytokine is found to decrease 
in patients with colorectal cancer.50 However, our 
study has several limitations. Firstly, the small 
sample size of the colorectal cancer and non-
colorectal cancer with less than 16 patients each 
may have led to chance occurance of statistically 
significant results. Secondly, although at 
inclusion criteria we did not include patients with 
yoghurt consumption and antibiotics using, but 
we cannot eliminate environment factors such 
as diet and everything related to microbiota. One 
of the interesting implications of this work is the 
potential of Bifidobacterium as a biomarker of 
cancer risk.
CONCLUSION
The results of our study suggests that 
the appearance of Bifidobacterium as one of 
indicator of detections for colorectal cancer. The 
expression of HSP-70 in patients with colorectal 
cancer were elevated with declining of caspase 
3 expression. Further studies are still needed to 
search the exact species of Bifidobacterium that 
abundant in predictive colorectal cancer patients
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